Biosimilars
Biotech
Regulatory
The US FDA Releases Drafts Guidance Recommending on Comparative Analytical
Shots: The US FDA has released guidance on the design and evaluation of comparative analytical studies that are supporting demonstration of biosimilarity, with the withdrawn of previous draft guidance approach […]readmore